Patents by Inventor Junhu Zhang

Junhu Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HIV-integrase inhibitors, pharmaceutical compositions, and methods for their use
    Patent number: 7001912
    Abstract: Beta-carboline hydroxamic acid compounds represented by formula (I) are described. The beta-carboline hydroxamic acid compounds and compositions containing those compounds may be used to inhibit or modulate the activity of HIV integrase enzyme and to treat HIV integrase-mediated diseases and conditions.
    Type: Grant
    Filed: January 26, 2004
    Date of Patent: February 21, 2006
    Assignee: Agouron Pharmaceuticals, Inc.
    Inventors: Atsuo Kuki, Xinqiang Li, Michael Bruno Plewe, Hai Wang, Junhu Zhang
  • Inhibitors of the HIV integrase enzyme
    Publication number: 20050277661
    Abstract: The present invention is directed to compounds of formula (i), and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as modulators or inhibitors of the human immunodeficiency virus (“HIV”) integrase enzyme.
    Type: Application
    Filed: April 25, 2005
    Publication date: December 15, 2005
    Inventors: Klaus Dress, Qiyue Hu, Ted Johnson, Michael Plewe, Steven Tanis, Huichun Zhu, Junhu Zhang
  • Inhibitors of the HIV integrase enzyme
    Publication number: 20050277662
    Abstract: The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as modulators or inhibitors of the human immunodeficiency virus (“HIV”) integrase enzyme.
    Type: Application
    Filed: April 25, 2005
    Publication date: December 15, 2005
    Inventors: Klaus Dress, Qiyue Hu, Ted Johnson, Michael Plewe, Steven Tanis, Hai Wang, Anle Yang, Chunfeng Yin, Junhu Zhang
  • HIV-integrase inhibitors, pharmaceutical compositions, and methods for their use
    Publication number: 20050165040
    Abstract: Beta-carboline hydroxamic acid compounds represented by formula (I) are described. The beta-carboline hydroxamic acid compounds and compositions containing those compounds may be used to inhibit or modulate the activity of HIV integrase enzyme and to treat HIV integrase-mediated diseases and conditions.
    Type: Application
    Filed: January 26, 2004
    Publication date: July 28, 2005
    Inventors: Atsuo Kuki, Xinqiang Li, Michael Plewe, Hai Wang, Junhu Zhang
  • HIV-integrase inhibitors, pharmaceutical compositions, and methods for their use
    Publication number: 20040147547
    Abstract: Bicyclic hydroxamate compounds represented by the Formula I: 1
    Type: Application
    Filed: October 30, 2003
    Publication date: July 29, 2004
    Applicant: Agouron Pharmaceuticals, Inc.
    Inventors: Qiyue Hu, Atsuo Kuki, Michael Bruno Plewe, Dawn Marie Nowlin, Hai Wang, Junhu Zhang